The importance of PTEN status in tumor cells was explored in preclinical models of melanoma cells[8], also confirming a strong correlation between tumor PTEN loss and T cell infiltration at tumor sites and supporting the rationale for further evaluate combinatorial strategies targeting PI3K-AKT to increase immune response to checkpoint inhibitors. This evidence concerns the gene PTEN and melanoma.